Vertex, Inc. ( NASDAQ:VERX ) recently posted some strong earnings, and the market responded positively. We have ...
VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.
Evercore ISI analyst Liisa Bayko maintained a Hold rating on Theravance Biopharma (TBPH – Research Report) today and set a price target ...
Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
CWA, one of the largest video game unions in the United States, have gone on strike. The action involves workers in ZeniMax ...
Formula One-owner Liberty Media will sharpen its focus on its motorsports businesses by spinning off most of its other assets ...
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity was originally published by The Motley Fool ...
ROI is in the forecast – 49% say they expect to achieve ROI through better forecasting and decision-making, closely followed by a more cost effective and future proofed technology architecture and a ...